Yatin Suneja is a Senior Managing Director and Equity Research Analyst at Guggenheim Securities, LLC, where he covers the Biotechnology sector with a focus on companies in the immunology, neurology, and inflammatory (INI) areas. With over 17 years of experience in equity research, Mr. Suneja brings deep expertise in analyzing and providing investment insights on biotechnology companies. Prior to joining Guggenheim in 2018, he held senior roles at SunTrust Robinson Humphrey and Cowen & Company, both specializing in biotechnology equity research. He began his career in Corporate Banking at Bank of America. Mr. Suneja holds an M.B.A. from Syracuse University and a bachelor’s degree from the University of Delhi.
